BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19966874)

  • 1. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audit of cervical screening in women with HIV infection in the Auckland and Northland regions of New Zealand.
    Grewal J; Lowe M; Gerrard H; Henley R; Perkins N; Briggs S
    N Z Med J; 2010 Jul; 123(1319):71-8. PubMed ID: 20717179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of quality assurance in an organized cervical screening program.
    Andrae B; Smith P
    Acta Obstet Gynecol Scand; 1999 May; 78(5):429-35. PubMed ID: 10326890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury.
    Simcock B; Sykes P; Laney M
    N Z Med J; 2001 Aug; 114(1138):378-80. PubMed ID: 11589435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let's talk about smear tests: social marketing for the National Cervical Screening Programme.
    Bethune GR; Lewis HJ
    Public Health; 2009 Sep; 123 Suppl 1():e17-22. PubMed ID: 19740498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the screening history of Alberta women with invasive cervical cancer.
    Stuart GC; McGregor SE; Duggan MA; Nation JG
    CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit of a cervical smear screening programme.
    Moodie PJ; Kljakovic M; McLeod DK
    N Z Med J; 1989 Jul; 102(872):374-6. PubMed ID: 2797554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fitzroy Valley Pap Smear Register. Cervical screening in a population of Australian aboriginal women.
    Mak DB; Straton JA
    Med J Aust; 1993 Feb; 158(3):163-6. PubMed ID: 8450781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Organized cervical cancer screening for underpriviledged women].
    Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
    Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry.
    Pettersson F; Näslund I; Malker B
    IARC Sci Publ; 1986; (76):91-105. PubMed ID: 3570419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.